Apheresis Market – Global Industry Insights,
Trends, Size, Share, Outlook, and Opportunity
Analysis, 2018–2026
Apheresis is a procedure of blood purification and blood component separation by using
centrifugation or membrane filtration technology. This procedure is performed for blood donation
component or for the treatment of disease. In this procedure, the blood is extracted from the patient
or from the donor’s body with the help of the apheresis machine and desired blood components are
separated on the basis of their molecular size and weight. The remaining blood is transferred back
to the patient’s or to the donor’s body. Apheresis procedure is performed for various diseases such
as neurological, cardiovascular, renal, autoimmune, hematological and other diseases.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/517
The devices used in apheresis procedure are centrifugation and membrane filtration devices. The
centrifuge therapeutic apheresis device is used in the separation of plasma or blood components
from the whole blood. These devices are automated continuous-flow systems and are used to
perform therapeutic plasma exchange, to remove plasma components or fluids, furthermore these
devices are used to perform red blood cells exchange.
The various procedures performed in apheresis are plasma (plasmapheresis), platelets
(plateletpheresis) and leukocytes (leukapheresis). Among these procedures, the plateletpheresis is
the most common procedure performed for supplying human leukocyte antigen (HLA) platelets to
the patient who have become HLA sensitized. In plasmapheresis procedure the plasma can be
removed to supply blood components, such as red blood cells, white blood cells and platelets. The
leukapheresis is the procedure in which white blood cells (WBC) are either separated or decreased
from the blood sample of the patient for the blood cell count. It is also performed to obtain the
patient's own blood cells for later transplant to use in chemotherapy treatments. The above reasons
are expected to favor growth of the apheresis market.
Rise in incidence of chronic disease cases such as cancer inadvertently augments growth of the
apheresis market. For instance, as per stats released by WHO, around 14 million new cases of